Equine p-tau217 antibody and antigen (recombinant protein)

 Download 

Product information

Catalog No.	Description	US $ Price (per mg)
GMP-EQU-p-tau217-Ag01	Recombinant Equine p-tau217 protein	3090
GMP-EQU-p-tau217-Ab01	Anti-Equine p-tau217 mouse monoclonal antibody (mAb)	1953
GMP-EQU-p-tau217-Ab02	Anti-Equine p-tau217 mouse monoclonal antibody (mAb)	1953
GMP-EQU-p-tau217-Ab03	Anti-Equine p-tau217 human monoclonal antibody (mAb)	1953
GMP-EQU-p-tau217-Ab04	Anti-Equine p-tau217 human monoclonal antibody (mAb)	1953

Size： 1mg | 10mg | 100mg

Product Description

Cat No. of Products	GMP-EQU-p-tau217-Ag01
Product Name	Recombinant Equine p-tau217 protein
Target/Biomarker	Equine Phospho-tau217 (p-tau217)
Expression platform	E.coli
Isotypes	Recombinant Antigen
Bioactivity validation	Anti-Equine Phospho-tau217 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in p-tau217 level test of animal Equine/Horse with Alzheimer Disease(AD).
Tag	His
Products description	Recombinant Equine p-tau217 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-EQU-p-tau217-Ab01, GMP-EQU-p-tau217-Ab02
Product Name	Anti-Equine p-tau217 mouse monoclonal antibody (mAb)
Target/Biomarker	Equine Phospho-tau217 (p-tau217)
Expression platform	CHO
Isotypes	Mouse IgG
Bioactivity validation	Recombinant Equine Phospho-tau217 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-p-tau217 antibodies in p-tau217 level test of animal Equine/Horse with Alzheimer Disease(AD).
Tag	mFc
Products description	Anti-Equine p-tau217 mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-p-tau217 antibodies.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-EQU-p-tau217-Ab03, GMP-EQU-p-tau217-Ab04
Product Name	Anti-Equine p-tau217 human monoclonal antibody (mAb)
Target/Biomarker	Equine Phospho-tau217 (p-tau217)
Expression platform	CHO
Isotypes	Human IgG1
Bioactivity validation	Recombinant Equine Phospho-tau217 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-p-tau217 antibodies in p-tau217 level test of animal Equine/Horse with Alzheimer Disease(AD).
Tag	hFc
Products description	Anti-Equine p-tau217 human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-p-tau217 antibodies.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference

Validation Data

Click to get more Data / Case study about the product.

Associated products

Target/Biomarker information

Equine p-tau217, the phosphorylated Tau Protein 217 variant specific to horses, stands as a sentinel within the intricate landscape of equine neurobiology. At its core, it is a Tau protein that has undergone precise phosphorylation at residue 217. Under normal circumstances, Tau proteins serve as the guardians of microtubule stability within neuronal cells, ensuring proper intracellular transport and the structural integrity of axons. However, when the stage is set for neurodegenerative processes, the narrative takes a different turn. Phosphorylation events can lead to the misfolding and aggregation of Tau proteins, and equine p-tau217 is no exception. It tends to aggregate and form neurofibrillary tangles within the neural tissues of afflicted horses. These neurofibrillary tangles, reminiscent of those observed in human neurodegenerative diseases such as Alzheimer's, serve as a pathological signature of various equine neurodegenerative conditions. The accumulation of p-tau217 in neurofibrillary tangles contributes to progressive neuronal dysfunction, ultimately manifesting as clinical signs in conditions like equine neuroaxonal dystrophy (eNAD) and specific encephalopathies.

About GDU